COVID-19 pandemic
The government approves the use of the Pfizer–BioNTech COVID-19 vaccine for children between the ages of 12 and 15, becoming the first vaccine to be approved used for children in Japan.
Sources: Kyodo News
Changes
- The Japanese government approves the usage of the Pfizer–BioNTech COVID-19 vaccine for children aged 12 to 15, becoming the first vaccine to be used for children in the country.
- The government approves the usage of the Pfizer–BioNTech COVID-19 vaccine for children aged 12 to 15, becoming the first vaccine to be used for children in Japan.
- The government approves the use of the Pfizer–BioNTech COVID-19 vaccine for children between the ages of 12 and 15, becoming the first vaccine to be approved used for children in Japan.
Related
New Zealand receives 60,000 doses of the Pfizer–BioNTech vaccine.